Safety and Efficacy of Fecal Microbiota Transplantation
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Autism
- Alcohol Dependence
- Alopecia
- Graft -Versus-host-disease
- Psoriatic Arthropathy
- Atopy or Allergy
- Hepatic Encephalopathy
- Multiple Sclerosis
- Irritable Bowel Syndrome
- Carbapenem-Resistant Enterobacteriaceae Infection
- MRSA Enteritis
- Celiac Disease
- Clostridium Difficile Infection
- Vancomycin Resistant Enterococci Infection
- Multiple Organ Dysfunction Syndrome
- Pseudo-Obstruction
- Constipation
- Crohn Disease
- Functional Dysphonia
- Pseudomembranous Enterocolitis
- Obesity
- Liver Disease
- Multidrug -Resistant Infection
- Ulcerative Colitis
- Idiopathic Thrombocytopenic Purpura
- Diabetes Mellitus
- Dysbiotic Bowel Syndrome
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: Non-RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Younger than 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04014413
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Siew Ng Chinese University of Hong Kong